NEW YORK--(BUSINESS WIRE)--Marwood Group, a leading, global healthcare advisory firm known for its deep expertise at the intersection of healthcare policy and commercial strategy, announced today the appointment of Nayan Ghosh as Director, Head of Life Sciences & HealthTech.

纽约--（商业新闻短讯）--马伍德集团是一家领先的全球医疗保健咨询公司，以其在医疗保健政策和商业战略交叉领域的深厚专业知识而闻名，今天宣布任命Nayan Ghosh为生命科学与健康技术总监。

After first joining Marwood in 2017 to help expand the market access and commercial strategy capabilities of the Life Sciences & HealthTech practice, Ghosh took a hiatus in 2021 to serve as Head of Commercial & Regulatory Strategy at Arcade Therapeutics, targeting some of the first FDA authorizations for non-drug anxiety and depression treatments..

在2017年首次加入马伍德，以帮助扩大生命科学与健康技术实践的市场准入和商业战略能力后，戈什于2021年中断工作，担任Arcade Therapeutics的商业与监管战略负责人，目标是获得FDA首批非药物焦虑和抑郁治疗授权。。

“Over the last decade, Marwood’s focus on Life Sciences & HealthTech has grown significantly, driven by its synergy with Marwood’s deep expertise, data and analytics capabilities related to healthcare services and delivery. Nayan played a large role in leading this growth, and we are excited to have him return,” said Marwood’s Senior Managing Director Lee Alvarez..

“在过去十年中，马伍德对生命科学与健康技术的关注显著增长，这得益于其与马伍德在医疗服务和交付方面深厚的专业知识、数据和分析能力的协同作用。纳扬在引领这一增长方面发挥了重要作用，我们很高兴他能回来，”马伍德的高级董事总经理李·阿尔瓦雷斯说道。。

Marwood’s Life Sciences & HealthTech practice provides guidance related to market access, evidence, policy, and commercial strategy to investors, service providers, developers, and manufacturers of emerging innovations with the potential to transform the treatment, management, prevention, or diagnosis of disease..

马伍德的生命科学与健康技术实践为投资者、服务提供商、开发商和新兴创新的制造商提供了与市场准入、证据、政策和商业策略相关的指导，这些创新有可能改变疾病的治疗、管理、预防或诊断。。

“The mission of Marwood’s Life Sciences & HealthTech practice is to help life-changing healthcare innovations get into the hands of the patients and practitioners who need them,” said Ghosh. “However, healthcare systems are complex, and regulatory, reimbursement, and policy dynamics are slow to catch up to the dizzying pace of new breakthroughs, ranging from AI-based pathology to cell and gene therapy.

戈什说：“马伍德生命科学与健康技术实践的使命是帮助改变生活的医疗保健创新进入需要它们的患者和从业者的手中。”。“然而，医疗保健系统是复杂的，监管、报销和政策动态很难跟上新突破的令人眩晕的步伐，从基于人工智能的病理学到细胞和基因治疗。

I look forward to helping navigate these complexities so that those working on these innovations see success at every stage of their products’ lifecycles.”.

我期待着帮助应对这些复杂性，以便那些致力于这些创新的人在其产品生命周期的每个阶段都能看到成功。”。

About Marwood Group

关于马伍德集团

As healthcare’s premier industry advisor, Marwood Group provides diligence and strategic consulting services to corporations and investors across provider, payor, HIT, outsourced services, and life sciences sectors. Marwood provides in-depth perspectives focused on policy, market strategy, reimbursement, compliance, big data analytics, and operations by leveraging its seasoned global team of healthcare professionals, proprietary data capabilities and extensive stakeholder reach.

作为医疗保健的首席行业顾问，马伍德集团为供应商、付款人、HIT、外包服务和生命科学领域的公司和投资者提供尽职调查和战略咨询服务。马伍德利用其经验丰富的全球医疗保健专业团队、专有数据能力和广泛的利益相关者覆盖范围，提供深入的视角，重点关注政策、市场战略、报销、合规性、大数据分析和运营。

Marwood is headquartered in New York City with offices in Washington DC and London. To learn more, visit www.marwoodgroup.com or follow us on LinkedIn..

马伍德总部位于纽约市，在华盛顿特区和伦敦设有办事处。要了解更多信息，请访问www.marwoodgroup.com或在LinkedIn上关注我们。。